The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes. (Q55236647)
Jump to navigation
Jump to search
scientific article published in May 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes. |
scientific article published in May 2018 |
Statements
The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes. (English)
1 reference
Hanns Lochmüller
1 reference
Grace McMacken
1 reference
Dan Cox
1 reference
Andreas Roos
1 reference
Juliane Müller
1 reference
1 May 2018
1 reference
27
1 reference
9
1 reference
1556-1564
1 reference
16 February 2018
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference